There is an unmet need for accurate and continuous non-invasive blood pressure (cNIBP) monitoring. Problems stemming from inaccurate, intermittent (single-time-point) BP measurement and sub-therapeutic management of BP are particularly pronounced in hospitals, where currently, the only option for continuous measurement is the invasive intra-arterial catheter, which can lead to clinically significant complications. The other option, cuffed devices, provide only intermittent and often inaccurate BP readings.
Dynocardia’s proprietary ViTrack™ methodology is the technology behind ViTrack, a wrist- wearable device with the processing power to enable continuous beat-to-beat BP monitoring. ViTrack technology is poised to surmount century-old obstacles to obtaining accurate and continuous measurement of BP by enabling ambulatory and nocturnal measurement. Additionally, ViTrack technology holds great promise for improving outcomes in 1.5 billion people living with hypertension around the world, who are at heightened risk for stroke and heart attacks.
GOAL 3: GOOD HEALTH AND WELL-BEING
“We are so grateful to 3DS for their interest in our work and investment in our efforts” says Dynocardia founder Mohan Thanikachalam, MD. We believe that their state-of-the-art prototyping facilities located here in Boston, along with 3DS’s product-development-software portfolio, automated platform for clinical trial recruitment, and strength of their engineering, IT, and design teams worldwide will allow us to commercialize ViTrack™ much faster than we’d have been able to otherwise.
Over the coming decade, ViTrack has the potential to monitor BP in billions of people and aggregate this real-world data in the cloud for unprecedented research opportunities for the prevention of cardiovascular disease. In addition to BP, ViTrack can provide heart rate, respiratory and other valuable cardio-hemodynamic data.
The Dynocardia team is deeply committed to improving the lives of billions of people via accurate and continuous BP monitoring.
Studies estimate the annual number of deaths due to medical errors in the hundreds of thousands, so there is great incentive to revise the way the medical profession gains knowledge and experience. Advances in 3D printing technology and virtual simulation are creating new opportunities to improve the quality of treatments and patient safety.
Have you been in a situation where a generic treatment did not work very well for you or someone you know? Have you ever had that nagging feeling that maybe the doctor (as good as he or she may be) should really be treating YOU rather than a generalized representation of you?
One in 160 children has an autism spectrum disorder according to the United Nations. Children with autism have learning and developmental disorders, and represent a number higher than all others disabilities put together. In the US alone, over 6.4% children have special needs in terms of cognitive, motor and sensory processing skills.
Inaccurate medications kill five times more people than road accidents do in developed countries. In France alone, this costs 10 billion euros to the public health system.
The Living Heart Project aims to advance the development of safe and effective cardiovascular products and treatments by uniting engineering, scientific, and biomedical expertise to translate cutting-edge science into improved patient care. Through simulation and the creation of validated models, the project aims to provide personalized, interventional patient care.
Two 3D experiences, ultra realistic on a scientific point of view, were created through collaborative projects with technologic and scientific partners: "Staying Alive" and "Born To Be Alive".
"Staying Alive" is a serious game that allows to learn appropriate behaviors for first aid techniques.
For patients with chronic illnesses, a primary goal is to create the best possible quality of life for living with a disease. During diagnosis or clinical trials , recording data from patients is often done over a too short a period of time for a proper clinical conclusion.
Do you think your project is the next big thing?
Join the team !